InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,898.72
(
0.48%
)
US TECH 100
19,988.80
(
0.63%
)
Dow Jones
43,454.15
(
0.02%
)
Brent Oil
72.88
(
3.07%
)
Bitcoin
91,434.31
(
1.74%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: None

Thursday, 09/23/2010 8:48:11 AM

Thursday, September 23, 2010 8:48:11 AM

Post# of 92948
Revenue,

The Company’s revenues are generated from license and research agreements with collaborators.
First 6 months of 2010..approx. $410,000 in revenue(about $125K less than first 6 months of 2009) Deferred revenue $971K(not earned)

Genzyme Transgenics Corporation... less than 10% of revenue
Exeter Life Sciences, Inc...$61,500
START Licensing, Inc. ..$49,000
Terumo Corporation (less than 10% of revenue)
International Stem Cell Corporation ..$56,000
Transition Holdings, Inc.. $102,000
CHA Biotech and SCRMI ..$65,000

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up